PYXS
Price
$1.08
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
62.82M
15 days until earnings call
RXRX
Price
$5.75
Change
+$0.17 (+3.05%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.24B
13 days until earnings call
Ad is loading...

PYXS vs RXRX

Header iconPYXS vs RXRX Comparison
Open Charts PYXS vs RXRXBanner chart's image
Pyxis Oncology
Price$1.08
Change-$0.00 (-0.00%)
Volume$2.2K
Capitalization62.82M
Recursion Pharmaceuticals
Price$5.75
Change+$0.17 (+3.05%)
Volume$114.84K
Capitalization2.24B
PYXS vs RXRX Comparison Chart
Loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PYXS vs. RXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYXS is a Buy and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PYXS: $1.08 vs. RXRX: $5.58)
Brand notoriety: PYXS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYXS: 117% vs. RXRX: 91%
Market capitalization -- PYXS: $62.82M vs. RXRX: $2.24B
PYXS [@Biotechnology] is valued at $62.82M. RXRX’s [@Biotechnology] market capitalization is $2.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYXS’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PYXS’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PYXS and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYXS’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PYXS’s TA Score: 4 bullish, 3 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than RXRX.

Price Growth

PYXS (@Biotechnology) experienced а +15.64% price change this week, while RXRX (@Biotechnology) price change was +4.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

PYXS is expected to report earnings on Aug 19, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.24B) has a higher market cap than PYXS($62.8M). RXRX YTD gains are higher at: -17.456 vs. PYXS (-30.769). PYXS has higher annual earnings (EBITDA): -64.04M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PYXS (145M). PYXS has less debt than RXRX: PYXS (20.5M) vs RXRX (108M). RXRX has higher revenues than PYXS: RXRX (58.5M) vs PYXS (16.1M).
PYXSRXRXPYXS / RXRX
Capitalization62.8M2.24B3%
EBITDA-64.04M-426.72M15%
Gain YTD-30.769-17.456176%
P/E RatioN/AN/A-
Revenue16.1M58.5M28%
Total Cash145M594M24%
Total Debt20.5M108M19%
TECHNICAL ANALYSIS
Technical Analysis
PYXSRXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMD90.394.13
+4.79%
Advanced Micro Devices
MREO2.560.06
+2.40%
Mereo BioPharma Group plc
PRO16.700.39
+2.39%
Pros Holdings
VANI1.040.02
+1.86%
Vivani Medical
FR47.100.75
+1.62%
First Industrial Realty Trust

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been closely correlated with KURA. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+5.88%
KURA - PYXS
67%
Closely correlated
+0.95%
BLRX - PYXS
45%
Loosely correlated
+2.41%
ABOS - PYXS
42%
Loosely correlated
+3.86%
BEAM - PYXS
41%
Loosely correlated
+3.87%
RXRX - PYXS
39%
Loosely correlated
-0.89%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.89%
CRSP - RXRX
72%
Closely correlated
-1.76%
BEAM - RXRX
62%
Loosely correlated
+3.87%
NTLA - RXRX
60%
Loosely correlated
-2.65%
ABSI - RXRX
59%
Loosely correlated
-0.47%
PRME - RXRX
59%
Loosely correlated
+4.14%
More